Suppr超能文献

聚(乳酸-共-乙醇酸)酸控制释放系统:实验和建模的见解。

Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.

机构信息

Department of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts, USA.

出版信息

Crit Rev Ther Drug Carrier Syst. 2013;30(3):257-76. doi: 10.1615/critrevtherdrugcarriersyst.2013006475.

Abstract

Poly(lactic-co-glycolic acid) (PLGA) has been the most successful polymeric biomaterial used in controlled drug delivery systems. There are several different chemical and physical properties of PLGA that impact the release behavior of drugs from PLGA delivery devices. These properties must be considered and optimized in the formulation of drug release devices. Mathematical modeling is a useful tool for identifying, characterizing, and predicting mechanisms of controlled release. The advantages and limitations of poly(lactic-co-glycolic acid) for controlled release are reviewed, followed by a review of current approaches in controlled-release technology that utilize PLGA. Mathematical modeling applied toward controlled-release rates from PLGA-based devices also will be discussed to provide a complete picture of a state-of-the-art understanding of the control that can be achieved with this polymeric system, as well as the limitations.

摘要

聚(乳酸-共-乙醇酸)(PLGA)是最成功的用于控制药物释放系统的聚合物生物材料。PLGA 有几种不同的化学和物理性质会影响药物从 PLGA 给药装置中的释放行为。在药物释放装置的配方中必须考虑并优化这些性质。数学建模是一种有用的工具,可用于识别、描述和预测控制释放的机制。本文综述了聚(乳酸-共-乙醇酸)用于控制释放的优缺点,然后综述了利用 PLGA 的当前控制释放技术方法。还将讨论应用于基于 PLGA 的装置的控制释放速率的数学建模,以提供对该聚合体系可实现的控制以及局限性的最新理解的全貌。

相似文献

1
Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
Crit Rev Ther Drug Carrier Syst. 2013;30(3):257-76. doi: 10.1615/critrevtherdrugcarriersyst.2013006475.
5
Protein instability in poly(lactic-co-glycolic acid) microparticles.
Pharm Res. 2000 Oct;17(10):1159-67. doi: 10.1023/a:1026498209874.
7
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.
Int J Pharm. 2011 Aug 30;415(1-2):34-52. doi: 10.1016/j.ijpharm.2011.05.049. Epub 2011 May 27.
9
Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
AAPS PharmSciTech. 2013 Jun;14(2):585-92. doi: 10.1208/s12249-013-9943-3. Epub 2013 Mar 6.

引用本文的文献

1
Phages and Control of -Associated Human, Animal, and Plant Diseases.
Microorganisms. 2025 Aug 11;13(8):1873. doi: 10.3390/microorganisms13081873.
3
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy.
Mol Cancer. 2025 Jul 24;24(1):205. doi: 10.1186/s12943-025-02410-x.
4
Application of Polyglycolic Acid/Poly (Lactic-co-glycolic Acid) in Thread Embedding Acupuncture for Obesity: New Strategies and Challenges.
Diabetes Metab Syndr Obes. 2025 Jul 5;18:2175-2189. doi: 10.2147/DMSO.S525783. eCollection 2025.
7
Immune Modulation with Oral DNA/RNA Nanoparticles.
Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.
8
Hyaluronic acid-loaded drug-eluting nanofibrous pad for the treatment of degenerative arthritis.
RSC Adv. 2025 May 12;15(20):15505-15515. doi: 10.1039/d5ra01494h.
9
Antimicrobial Performance of a Novel Drug-Eluting Bioenvelope.
Antibiotics (Basel). 2025 Mar 21;14(4):330. doi: 10.3390/antibiotics14040330.
10
Rubber-like and Antifouling Poly(trimethylene carbonate-ethylphosphonate) Copolymers with Tunable Hydrolysis.
ACS Appl Mater Interfaces. 2025 Apr 23;17(16):23513-23521. doi: 10.1021/acsami.4c21079. Epub 2025 Apr 14.

本文引用的文献

2
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.
Polymers (Basel). 2011 Sep 1;3(3):1377-1397. doi: 10.3390/polym3031377. Epub 2011 Aug 26.
3
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Biomaterials. 2010 Feb;31(5):908-15. doi: 10.1016/j.biomaterials.2009.09.104. Epub 2009 Oct 22.
4
Poly (lactic-co-glycolic acid) as a controlled release delivery device.
J Mater Sci Mater Med. 2009 Aug;20(8):1669-75. doi: 10.1007/s10856-009-3727-z. Epub 2009 Mar 13.
5
Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering.
Biomaterials. 2009 May;30(13):2571-81. doi: 10.1016/j.biomaterials.2008.12.073. Epub 2009 Jan 20.
6
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.
7
Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering.
Acta Biomater. 2009 Jan;5(1):305-15. doi: 10.1016/j.actbio.2008.07.019. Epub 2008 Jul 31.
8
PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs.
Biomed Mater. 2007 Dec;2(4):269-73. doi: 10.1088/1748-6041/2/4/010. Epub 2007 Nov 2.
10
Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
J Control Release. 2008 Apr 21;127(2):146-53. doi: 10.1016/j.jconrel.2008.01.017. Epub 2008 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验